|
Implementation of care near home model (CNH) for cancer patients in response to COVID-19 pandemic. |
|
|
Research Funding - MSD Oncology |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Biologix Solutions; Janssen; Novartis; Takeda |
Travel, Accommodations, Expenses - Biologix Solutions; MSD; Pfizer; Roche; Takeda |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |